ribavirin tablet

DRUG4 trials

Sponsors

Gilead Sciences

Conditions

Chronic Genotype 1a or 1b HCV InfectionHepatitis C, Chronic

Phase 2

GS 5885 Administered Concomitantly With GS-9451, Tegobuvir and Ribavirin (RBV) in Chronic Genotype 1 Hepatitis C Virus (HCV) Infection

CompletedNCT01353248

Gilead SciencesHepatitis C, Chronic

Start: 2011-05-31End: 2013-03-31Updated: 2013-12-20

GS-5885 Alone or in Combination With GS-9451 With Peginterferon Alfa 2a and Ribavirin in Treatment Chronic Genotype 1 Hepatitis C Virus

CompletedNCT01356160

Gilead SciencesHepatitis C, Chronic

Start: 2011-07-31End: 2013-06-30Updated: 2014-02-03

Oral Antivirals (GS-5885, Tegobuvir, and/or GS-9451) With Peginterferon Alfa 2a and Ribavirin in Treatment Experienced Subjects With Chronic Genotype 1 Hepatitis C Virus Infection

CompletedNCT01371578

Gilead SciencesHepatitis C, Chronic

Start: 2011-07-31End: 2013-03-31Updated: 2014-02-11

GS-5885, GS-9451, Tegobuvir and Ribavirin (RBV) in Interferon Ineligible or Intolerant Subjects With Chronic Genotype 1a or 1b Hepatitis C Virus (HCV) Infection

CompletedNCT01434498

Gilead SciencesChronic Genotype 1a or 1b HCV Infection

Start: 2011-09-30End: 2013-01-31Updated: 2013-12-20